The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.
Published: June 22, 2017 at 02:00AM
from NYT Health https://ift.tt/2s1g0DT